Avita Medical
RCEL | NASDAQ
$15.22
-$0.41 (-2.62%)
At close: Nov 16, 2026, 4:00 PM ET
$15.31
+$0.09 (+0.59%)
After-hours:
Nov 16, 2026, 7:32 PM ET
-2.62%
(1D)No price chart data available for 1D timeframe.
Rating
44.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #407/1021 (Top 40%)
Key Statistics
Market Data
Market Cap $469.78M
1D Range
14.74 15.97
52W Range
3.27 17.65
Valuation (TTM)
PE -12.79
PB -15.14
EV/EBITDA 764.98
Valuation (NTM)
Forward PE 28.83
Forward PEG 0.26
Price Target $12.00
Cash Flow
FCF Yield -3.9%
SBC Adj. FCF Yield -5.2%
SBC Impact -33.8%
Margins
Gross Margin 82.4%
Operating Margin -1.9%
FCF Margin -21.4%
Growth (CAGR)
Revenue 3Y | 5Y 23.1% |
22.1%
Dil EPS 3Y | 5Y 29.8% |
-3.1%
FCF 3Y | 5Y 54.3% |
0.1%
Returns
ROA -77.2%
ROE 146.4%
ROIC -120.8%
Financial Health
Net Debt
$36.63M
Current Ratio 1.20
Interest Coverage -5.11
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’...
Sector Healthcare
Industry Medical - Devices
Employees 226
IPO Date May 14, 2012
Website avitamedical.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.2
Beat +16.46%
YoY:
+56.52% REV
$26.11M
Beat +16.84%
YoY:
+53.05%Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$12.00
Downside
-21.16%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove RCEL